4.7 Review

The AMP-activated protein kinase (AMPK) and cancer: Many faces of a metabolic regulator

Journal

CANCER LETTERS
Volume 356, Issue 2, Pages 165-170

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2014.01.018

Keywords

AMPK; Tumor metabolism; mTOR; Warburg effect; HIF-1 alpha

Categories

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. McGill Integrated Cancer Research Training Program (MICTRP)
  3. CIHR [MOP-93799]
  4. Canadian Cancer Society [2010-700586]
  5. Terry Fox Research Foundation [TEF-116128]

Ask authors/readers for more resources

The AMP-activated protein kinase (AMPK) is a central regulator of cellular metabolism and energy homeostasis in mammalian tissues. Pertinent to cancer biology is the fact that AMPK is situated in the center of a signaling network involving established tumor suppressors including LKB1, TSC2 and p53. However, recent- research suggests that AMPK can exert pro- or anti-tumorigenic roles in cancer depending on context. Loss of AMPK activity has been observed in several tumor types, and can cooperate with oncogenic drivers to reprogram tumor cell metabolism and enhance cell growth and proliferation. However, AMPK activation can also provide a growth advantage to tumor cells by regulating cellular metabolic plasticity, thus providing tumor cells the flexibility to adapt to metabolic stress. Here we discuss the contextual nature of the two faces of AMPK in cancer, and discuss the rationale and context for employing AMPK activators versus inhibitors for cancer therapy. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available